Skip to content
Evigrade
CriticalClass III antiarrhythmic, selective IKr blocker×Antifungal, triazole

Updated · Methodology

Mechanism

Dofetilide, a class III antiarrhythmic, prolongs the QT interval linearly with its dose and blood level (dofetilide label, US Food and Drug Administration, FDA). About 80% of a dofetilide dose leaves the body in the urine, partly through active renal secretion of cations, and the enzyme CYP3A4 metabolises it only to a small extent. Even so, the US label says that CYP3A4 inhibitors, including azole antifungals, may increase dofetilide levels (FDA). Itraconazole strongly inhibits CYP3A4, and although the pair has not been studied directly, the itraconazole summary of product characteristics (SmPC) says that itraconazole is likely to raise dofetilide levels (itraconazole SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). According to the Spanish and US itraconazole documents, higher levels of some of the CYP3A4 substrates contraindicated with it can prolong the QT interval and cause ventricular tachyarrhythmias, including life-threatening torsade de pointes (AEMPS, FDA). Ketoconazole is contraindicated with dofetilide as an inhibitor of renal cation secretion (FDA), but the itraconazole documents say nothing about such an effect, and the documents give no figures for this pair.

Symptoms

The main risk is QT prolongation and torsade de pointes ventricular tachycardia, which can be fatal (itraconazole summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS; dofetilide label, US Food and Drug Administration, FDA). QT prolongation itself causes no symptoms and shows only on an electrocardiogram (ECG), while an arrhythmia causes palpitations, dizziness and fainting. In people with supraventricular arrhythmias, torsade de pointes occurred in 0.8% of those taking dofetilide, more often at higher doses and mostly within the first three days of treatment, and low potassium and magnesium increase its risk (FDA). Itraconazole can cause new heart failure or make it worse. Signs include shortness of breath, swelling of the feet, ankles or legs, sudden weight gain, increased tiredness and a fast heartbeat (itraconazole label, FDA).

Management

The combination is contraindicated. The Spanish and US itraconazole documents name dofetilide among the drugs that must not be given during itraconazole treatment or for two weeks after it is stopped (itraconazole summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, and itraconazole label, US Food and Drug Administration, FDA). Dofetilide is not authorised in Spain, and its US label is less strict. It says to give CYP3A4 inhibitors, including azole antifungals, with caution and contraindicates only one azole, ketoconazole, as an inhibitor of renal cation secretion (dofetilide label, FDA). After itraconazole is stopped, its levels fall to almost undetectable within 7–14 days, and they fall even more slowly in liver cirrhosis or with other CYP3A4 inhibitors (itraconazole SmPC, AEMPS). If dofetilide is stopped to allow a potentially interacting drug, wait at least two days before starting that drug (dofetilide label, FDA). Start or restart dofetilide only in a facility that can calculate creatinine clearance, provide continuous electrocardiogram (ECG) monitoring and perform cardiac resuscitation, and keep the patient there for at least three days (FDA). Dofetilide is contraindicated if the QT or heart-rate-corrected QT interval (QTc) exceeds 440 ms (500 ms with ventricular conduction abnormalities). Bring potassium into the normal range before starting and keep it there throughout treatment (FDA). If at any time after the second dose the QT or QTc exceeds 500 ms (550 ms with conduction abnormalities), stop dofetilide (FDA). For torsade de pointes or overdose, options include an isoprenaline infusion, with or without cardiac pacing, and intravenous magnesium sulfate, with close monitoring until the QT interval returns to normal (FDA). If signs of heart failure appear, stop itraconazole (itraconazole SmPC, AEMPS, and itraconazole label, FDA).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Dofetilide

Other interactions with Itraconazole